厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压的效(基础医学范文).doc
文本预览下载声明
厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压的效(基础医学范文)
文档信息
属性:
F-00P818,doc格式,正文3515字。质优实惠,欢迎下载!
适用:
作为文章写作的参考文献,解决如何写好实用应用文、正确编写文案格式、内容摘取等相关工作。
作者:
佚名
目录
TOC \o 1-9 \h \z \u 目录 1
正文 1
搞要 1
关键字:厄贝沙坦;钙离子拮抗剂;老年2型糖尿病;肾病;高血压 2
1 资料与方法 3
2 结果 4
3 讨论 5
[参考文献] 5
论文原创声明(模板) 6
论文致谢(模板) 7
正文
厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压的效(基础医学范文)
搞要
摘要:目的研究厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压的临床疗效。方法选取该院2014年3月―2017年3月收治的52例老年2型糖尿病肾病合并高血压患者,将他们随机分为两组,观察组(n=26)和对照组(n=26)。其中对照组利用厄贝沙坦联合非洛地平缓释片进行治疗,观察组利用厄贝沙坦和硝苯地平控释片两种药物联合进行治疗,对比分析两组患者的临床疗效与不良反应发生情况。结果观察组患者的临床治疗效果(%)明显高于对照组(%)(P)。经对比,观察组治疗后的SBP和血肌酐数值均低于对照组(P),不良反应发生率低,两组比较差异无统计学意义(P)。结论明显看出厄贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病肾病合并高血压患者中有着明显的临床治疗效果,不良反应发生率低,值得进一步推广和应用
关键字:厄贝沙坦;钙离子拮抗剂;老年2型糖尿病;肾病;高血压
[中图分类号] R9 [文献标识码] A [文章编号] 1672-4062(2017)12(a)-0103-02
[Abstract] Objective This paper tries to study the clinical efficacy of irbesartan combined with calcium antagonist in the treatment of elderly type 2 diabetic nephropathy with hypertension. Methods 52 elderly patients with type 2 diabetic nephropathy with hypertension were enrolled in this hospital from March 2014 to March 2017. They were randomly divided into two groups: observation group(n=26) and control group (n=26) ). The control group was treated with irbesartan and felodipine sustained-release tablets. The observation group was treated with irbesartan and nifedipine GITS, and the clinical efficacy and side effects of the two groups were compared. Results The clinical efficacy of the observation group (%) was significantly higher than that of the control group(%)(). Conclusion It is obvious that irbesartan and calcium antagonists have obvious clinical effect in the treatment of type 2 diabetic nephropathy with hypertension in elderly patients. The incidence of adverse reactions is low and worthy of further promotion and application.
[Key words] Irbesartan; Calcium antagonists; Senile type 2 diabetes; Nephropathy; Hypertension
糖尿病是一种主要症状为高血糖的代谢性疾病[1],近些年,随着社会的发展进步,人们的生活方式及饮食习惯也发生了改变,所以养成了不健康的生活习惯,这是导
显示全部